Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003998
What this trial is testing

Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
University of Glasgow 1,050
Early research (Phase 1)Study completedNCT01253681
What this trial is testing

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer

Who this might be right for
CarcinomaFallopian Tube CancerOvarian Cancer+1 more
Amgen 27
Early research (Phase 1)Study completedNCT00079430
What this trial is testing

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+9 more
National Cancer Institute (NCI) 113
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Ended earlyNCT00331422
What this trial is testing

Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Ended earlyNCT00023907
What this trial is testing

Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Not applicableEnded earlyNCT00288275
What this trial is testing

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Precision Therapeutics 256
Testing effectiveness (Phase 2)Study completedNCT00096395
What this trial is testing

Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT01031381
What this trial is testing

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
University of Pittsburgh 50
Not applicableLooking for participantsNCT05912972
What this trial is testing

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+2 more
Asan Medical Center 13,500
Testing effectiveness (Phase 2)Looking for participantsNCT07514494
What this trial is testing

Intensification Treatment of Ovarian Cancer by PIPAC

Who this might be right for
Advanced Epithelial Ovarian CancerPeritoneal Carcinomatosis
Moscow Regional Oncological Dispensary 160
Testing effectiveness (Phase 2)Ended earlyNCT00004037
What this trial is testing

Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01834469
What this trial is testing

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

Who this might be right for
Ovarian CancerPeritoneal Carcinomatosis
Jules Bordet Institute 10
Early research (Phase 1)Study completedNCT01384253
What this trial is testing

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Who this might be right for
Breast NeoplasmsPeritoneal NeoplasmsOvarian Neoplasms+2 more
Orano Med LLC 18
Testing effectiveness (Phase 2)Looking for participantsNCT05739981
What this trial is testing

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Imunon 30
Testing effectiveness (Phase 2)Study completedNCT00036751
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Not Yet RecruitingNCT07532148
What this trial is testing

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
Chong Kun Dang Pharmaceutical 24
Not applicableStudy completedNCT03921658
What this trial is testing

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
University of Minnesota 255
Early research (Phase 1)Study completedNCT01294293
What this trial is testing

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Malignant Ovarian Mixed Epithelial TumorOvarian Brenner TumorOvarian Clear Cell Cystadenocarcinoma+7 more
Gynecologic Oncology Group 20
Not applicableLooking for participantsNCT03296826
What this trial is testing

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

Who this might be right for
BRCA1 and/or BRCA2 Variant CarriersOvarian CarcinomaFallopian Tube Carcinoma+1 more
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 600
Next Page